Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 2
1986 1
2000 2
2003 2
2005 1
2006 1
2008 3
2009 1
2012 1
2015 3
2016 7
2017 1
2019 1
2021 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study.
Reding MT, Pabinger I, Holme PA, Maas Enriquez M, Mancuso ME, Lalezari S, Miesbach W, Di Minno G, Klamroth R, Hermans C. Reding MT, et al. Among authors: maas enriquez m. Ther Adv Hematol. 2023 Apr 22;14:20406207231166779. doi: 10.1177/20406207231166779. eCollection 2023. Ther Adv Hematol. 2023. PMID: 37113811 Free PMC article.
Parvovirus B19 in idiopathic thrombocytopenic purpura.
Wehmeier A, Eis-Hübinger AM, Maas Enriquez M, Beckmann H. Wehmeier A, et al. Among authors: maas enriquez m. Vox Sang. 2000;79(2):118. doi: 10.1159/000031224. Vox Sang. 2000. PMID: 11054052 No abstract available.
Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94-9027 in severe haemophilia A: final results of the PROTECT VIII extension study.
Reding MT, Pabinger I, Holme PA, Poulsen L, Negrier C, Chalasani P, Maas Enriquez M, Wang M, Meijer K, Mancuso ME, Lalezari S. Reding MT, et al. Among authors: maas enriquez m. Haemophilia. 2021 May;27(3):e347-e356. doi: 10.1111/hae.14297. Epub 2021 Apr 5. Haemophilia. 2021. PMID: 33818853 Free PMC article. Clinical Trial.
BAY 94-9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results.
Lalezari S, Reding MT, Pabinger I, Holme PA, Negrier C, Chalasani P, Shin HJ, Wang M, Tseneklidou-Stoeter D, Maas Enriquez M. Lalezari S, et al. Among authors: maas enriquez m. Haemophilia. 2019 Nov;25(6):1011-1019. doi: 10.1111/hae.13853. Epub 2019 Oct 17. Haemophilia. 2019. PMID: 31621991 Free PMC article. Clinical Trial.
32 results